Press Releases Archive
Search in Press Releases
January
-
No. 01
05/01/2021 Anticoagulants reduce the number of brain metastases in mice -
No. 02c2
18/01/2021 How a protein variant could explain resistance to sleeping sickness drug -
No. 02a
20/01/2021 DKFZ and EMBL intensify cooperation -
No. 03
25/01/2021 Protein anchors as a newly discovered key molecule in cancer spread and epilepsy -
No. 03c
27/01/2021 How blood stem cells maintain their lifelong potential for self-renewal
February
-
No. 07
11/02/2021 Vitamin D supplementation: possible gain in life years plus cost savings -
No. 08c
23/02/2021 PSMA-binding agents: versatile against prostate cancer -
No. 09c
24/02/2021 Supposedly "silent" mutation with serious consequences
March
-
No. 14
04/03/2021 Induced pluripotent stem cells reveal causes of disease -
No. 16
15/03/2021 How novel pathogens may cause the development of colorectal cancer -
No. 16c
19/03/2021 New single-cell analysis of leucemic stem cells -
No. 17
24/03/2021 Vaccination against mutated protein tested in brain tumor patients for the first time -
No. 18
24/03/2021 Liver cancer: which patients benefit from immunotherapy?
April
-
No. 22c
13/04/2021 beLAB 2122: A new bridge connects research and industry -
No. 23
14/04/2021 Engineering T cells for cancer therapy efficiently and safely
May
-
No. 27
17/05/2021 Mahak Singhal awarded the Helmholtz Doctoral Prize 2020 -
No. 28
20/05/2021 Immune cells promote proinflammatory fatty liver disease -
No. 29
25/05/2021 How “paralyzed” immune cells can be reactivated against brain tumors -
No. 30c
26/05/2021 High-resolution molecular map of endothelial cells identifies new mechanisms of liver regeneration
June
-
No. 31c3
08/06/2021 Collaborative Research Center on the Wnt signaling pathway enters second funding period -
No. 36
21/06/2021 DKFZ Innovation Award presented for the first time -
No. 38
23/06/2021 Blood stem cells make brain tumors more aggressive
July
-
No. 40c
06/07/2021 High-throughput metabolic profiling of single cells -
No. 40c2
12/07/2021 Hijacked immune activator promotes growth and spread of colorectal cancer -
No. 41
19/07/2021 Why identical mutations cause different types of cancer -
No. 42
20/07/2021 Worth the extra input: Patient care in certified cancer centers - longer survival at a lower cost -
No. 43
26/07/2021 Vaccination against hereditary colorectal cancer successful in mice
August
-
No. 43c
09/08/2021 What leads to the exhaustion of immune cells in the tumor microenvironment? -
No. 46e
11/08/2021 How much does it really cost to develop a new drug? -
No. 47e
16/08/2021 Blood-based micro-RNAs indicate the risk of colorectal cancer -
No. 48e
18/08/2021 Superspreading events as drivers of SARS-CoV-2 evolution
September
-
No. 50e
02/09/2021 Award-winning science: Cancer-promoting metabolic pathways as targets of new therapies -
No. 49e
02/09/2021 Blood vessels produce growth factor that promotes metastases -
No. 51c2
14/09/2021 Bridging antibodies plus enhancer can destroy breast cancer cells -
No. 53e
21/09/2021 High risk of colorectal cancer in men only partly explainable
October
-
No. 55c
14/10/2021 Genomic tracking of the COVID-19 pandemic in England
